Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance.

Lau WC, Gurbel PA, Watkins PB, Neer CJ, Hopp AS, Carville DG, Guyer KE, Tait AR, Bates ER.

Circulation. 2004 Jan 20;109(2):166-71. Epub 2004 Jan 5.

2.

Resistance to clopidogrel: a review of the evidence.

Nguyen TA, Diodati JG, Pharand C.

J Am Coll Cardiol. 2005 Apr 19;45(8):1157-64. Review.

3.

Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.

Tourmousoglou CE, Rokkas CK.

Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):312-22. Review.

PMID:
18855644
4.

Drug interaction between clopidogrel and proton pump inhibitors.

Khalique SC, Cheng-Lai A.

Cardiol Rev. 2009 Jul-Aug;17(4):198-200. doi: 10.1097/CRD.0b013e3181a857ba. Review.

PMID:
19525682
5.

Thienopyridines and statins: assessing a potential drug-drug interaction.

Neubauer H, Mügge A.

Curr Pharm Des. 2006;12(10):1271-80. Review.

PMID:
16611111
6.
7.

Aspirin and clopidogrel resistance: consideration and management.

Gurbel PA, Tantry US.

J Interv Cardiol. 2006 Oct;19(5):439-48. Review.

PMID:
17020569
8.

Clopidogrel resistance.

Oqueli E, Hiscock M, Dick R.

Heart Lung Circ. 2007;16 Suppl 3:S17-28. Epub 2007 Jul 3. Review.

PMID:
17611155
9.

Clopidogrel resistance: implications for coronary stenting.

Gurbel PA, Lau WC, Bliden KP, Tantry US.

Curr Pharm Des. 2006;12(10):1261-9. Review.

PMID:
16611110
10.

Clopidogrel pharmacogenetics and its clinical implications.

Singh M, Thapa B, Arora R.

Am J Ther. 2010 May-Jun;17(3):e66-73. doi: 10.1097/MJT.0b013e3181afbf62. Review.

PMID:
19636246
11.

Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

Ben-Dor I, Kleiman NS, Lev E.

Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Review.

PMID:
19576352
12.

Drug-eluting stents and antiplatelet resistance.

Simon DI, Jozic J.

Am J Cardiol. 2008 Nov 3;102(9 Suppl):29J-37J. doi: 10.1016/j.amjcard.2008.09.007. Review.

PMID:
18928790
13.

Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.

Siller-Matula J, Schrör K, Wojta J, Huber K.

Thromb Haemost. 2007 Mar;97(3):385-93. Review.

PMID:
17334505
14.

Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.

Ma TK, Lam YY, Tan VP, Kiernan TJ, Yan BP.

Pharmacol Ther. 2010 Feb;125(2):249-59. doi: 10.1016/j.pharmthera.2009.10.008. Epub 2009 Nov 14. Review.

PMID:
19919843
15.

The role of the cytochrome P450 polymorphisms in clopidogrel efficacy and clinical utility.

Tousoulis D, Siasos G, Zaromytidou M, Papageorgiou N, Stefanadi E, Oikonomou E, Stefanadis C.

Curr Med Chem. 2011;18(3):427-38. Review.

PMID:
21143117
16.

[Variable extent of platelet responsiveness to clopidogrel inhibition: "clopidogrel resistance"?].

Morel O, Ohlmann P, Jesel L, Morel N, Ridard C, Faure A, Grunebaum L, Toti F, Bareiss P.

Ann Cardiol Angeiol (Paris). 2005 Aug;54(4):194-200. Review. French.

PMID:
16104620
18.

Interactions between clopidogrel and proton pump inhibitors: a review of evidence.

Muñoz-Esparza C, Jover E, Hernández-Romero D, Saura D, Valdés M, Lip GY, Marín F.

Curr Med Chem. 2011;18(16):2386-400. Review.

PMID:
21568918
19.

[Statin and clopidogrel pharmacological interaction].

Leoncini M, Toso A, Maioli M, Bellandi F.

G Ital Cardiol (Rome). 2013 Sep;14(9):574-84. doi: 10.1714/1311.14483. Review. Italian.

PMID:
23903277
20.

An insight into the interaction between clopidogrel and proton pump inhibitors.

Shah BS, Parmar SA, Mahajan S, Mehta AA.

Curr Drug Metab. 2012 Feb;13(2):225-35. Review.

PMID:
22300021

Supplemental Content

Support Center